Heart Rhythm Society (HRS)

The Heart Rhythm Society (HRS) is the primary U.S. medical society for electrophysiology (EP). The organization promotes education and advocacy for cardiac arrhythmia professionals and patients, including setting policy guidelines and offering expert consensus.

RSS icon
The proliferation of artificial intelligence (AI) in healthcare includes numerous algorithms for electrophysiology (EP). Jagmeet Singh, MD, Professor of Medicine, Harvard Medical School, and founding director of the Resynchronization and Advanced Cardiac Therapeutics Program and Mass General Hospital, spoke with Cardiovascular Business at Heart Rhythm 2023 to explain how AI is being used in EP. #HRS2023 #HRS #AI

AI gaining popularity in electrophysiology

There are now numerous AI algorithms for electrophysiology. Jagmeet Singh, MD, examined how this advanced technology is being applied.

Daniel Cantillon, MD, said the first leadless, dual-chamber pacing system performed very well in the Aveir dual-chamber i2i trial. #HRS #HRS23

Early success of dual-chamber leadless pacemaker suggests big changes could be on the horizon

Daniel Cantillon, MD, explained why the positive performance of Abbott's Aveir dual-chamber leadless pacemaker could lead to considerable improvements in patient care. 

A figure from the HRS remote monitoring consensus document on staffing challenges with remote monitoring.

Electrophysiology experts issue recommendations for remote monitoring of CIEDs

The Heart Rhythm Society released a new expert consensus statement on the management of remote device clinics for implantable EP devices.

The EBR Systems WiSE leadless cardiac resynchronization therapy (CRT) system. #HRS23

A leadless pacemaker the size of a grain of rice delivers cardiac resynchronization therapy

Results from a pivotal clinical trial presented as a late-breaker at Heart Rhythm 2023 indicate that a new leadless pacemaker technology can deliver cardiac resynchronization therapy in patients who were not able to be treated with conventional CRT and epicardial leads.

Left bundle branch pacing emerges as an alternative to biventricular pacing in two late-breaking trials

The use of left bundle branch area pacing (LBBAP) is growing in electrophysiology implanted devices. Two late-breaking studies at Heart Rhythm 2023 highlight the success of LBBAP as an alternative to the standard of care using biventricular pacing.

Thumbnail

Links to all the late-breaking trials for Heart Rhythm 2023

Heart Rhythm 2023, the society's 44th annual meeting, is scheduled for May 19-21. 

Images from the consensus document showing the proper left atrial appendage (LAA) sizing assessment for a transcatheter occluder device using transesophageal echo (TEE). Sizing and evaluation for pre-existing thrombus in the LAA also can be performed using cardiac CT.

SCAI and HRS release expert consensus on transcatheter left atrial appendage occlusion

One of the new recommendations is to conduct baseline imaging with TEE or cardiac CT.

Cardiologists, electrophysiologists ‘disappointed’ in final 2023 Medicare Physician Fee Schedule

The American College of Cardiology and Heart Rhythm Society issued a joint statement soon after CMS published its final rule for the 2023 Medicare Physician Fee Schedule. The groups warned that the final rule could threaten patient access to high-quality care. 

Displaying 41 - 48 of 63
Design by Adaptive Theme